vimarsana.com

Page 10 - நைஜீரியன் நிறுவனம் ஆஃப் மருத்துவ ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hope rising for Lassa fever vaccine

Punch Newspapers Sections IT is heartening that efforts are ongoing to develop a vaccine for Lassa fever. An American biotechnology company, INOVIO, which is spearheading the research, noted that the first participant in Lassa vaccine trial had been dosed in a Phase 1B clinical trial for INO-4500, its DNA vaccine candidate for Lassa fever. The clinical trial in progress in Ghana is reportedly focusing on offering precisely-designed DNA medicines to treat and protect people from infectious diseases and cancer. Lassa fever, according to the United States Centres for Disease Control and Prevention, is an animal-borne, or zoonotic, acute viral illness. It is endemic in parts of West Africa, including Sierra Leone, Liberia, Guinea and Nigeria. The illness was discovered in 1969 and is named after the town in Nigeria where the first cases occurred. The CDC says an estimated 100,000 to 300,000 infections of Lassa fever occur annually, with approximately 5,000 deaths. The World Health O

1 in 5 people in Lagos may have contracted COVID-19, NCDC, NIMR say

And for Gombe State, it was 1 in 10 persons. “Survey findings released today revealed that the prevalence of SARS-CoV-2 antibodies was 23% in Lagos and Enugu States, 19% in Nasarawa State, and 9% in Gombe State,” NCDC and NIMR said in a statement. “This means that as many as 1 in 5 individuals in Lagos, Enugu and Nasarawa State would have ever been infected with SARS-CoV-2. In Gombe, the proportion is about 1 in 10.” Lagos State is the epicenter of the virus in Nigeria and has the highest burden of the virus in the country – official statistics show that the state has recorded 55, 122 confirmed cases and 403 deaths from the virus as of February 24.

Facing Roadblocks, Vast Global Vaccination Effort Gets Underway

Facing Roadblocks, Vast Global Vaccination Effort Gets Underway An operation to supply billions of coronavirus vaccine doses to poorer countries has started. But as rich countries buy most of the available supply, stark inequalities remain. The first shipment of Covid-19 vaccines distributed by the Covax facility arriving at Kotoka International Airport in Accra, Ghana.Credit.Francis Kokoroko/UNICEF Feb. 24, 2021 DAKAR, Senegal A long-awaited global sharing program designed to make vaccine access more equal began on Wednesday, when hundreds of thousands of doses arrived in the West African nation of Ghana the first of two billion that organizers hope to deliver worldwide this year.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.